BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 32844199)

  • 1. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
    Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q
    Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
    Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
    Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
    Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
    Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.
    Wen C; Zheng Z; Shao T; Liu L; Xie Z; Le Chatelier E; He Z; Zhong W; Fan Y; Zhang L; Li H; Wu C; Hu C; Xu Q; Zhou J; Cai S; Wang D; Huang Y; Breban M; Qin N; Ehrlich SD
    Genome Biol; 2017 Jul; 18(1):142. PubMed ID: 28750650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
    Rosario D; Bidkhori G; Lee S; Bedarf J; Hildebrand F; Le Chatelier E; Uhlen M; Ehrlich SD; Proctor G; Wüllner U; Mardinoglu A; Shoaie S
    Cell Rep; 2021 Mar; 34(9):108807. PubMed ID: 33657381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
    Palacios N; Wilkinson J; Bjornevik K; Schwarzschild MA; McIver L; Ascherio A; Huttenhower C
    Ann Neurol; 2023 Sep; 94(3):486-501. PubMed ID: 37314861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
    Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
    Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q
    Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the gut microbiome in Egyptian patients with Parkinson's Disease.
    Mehanna M; AbuRaya S; Ahmed SM; Ashmawy G; Ibrahim A; AbdelKhaliq E
    BMC Microbiol; 2023 Jul; 23(1):196. PubMed ID: 37481569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
    Wang S; Li N; Zou H; Wu M
    Neurosci Lett; 2019 Mar; 696():93-98. PubMed ID: 30572101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 14. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
    Heravi FS; Naseri K; Hu H
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The gut microbiome in Parkinson's disease].
    Bedarf JR; Hildebrand F; Goeser F; Bork P; Wüllner U
    Nervenarzt; 2019 Feb; 90(2):160-166. PubMed ID: 30171304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.
    Aho VTE; Pereira PAB; Voutilainen S; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    EBioMedicine; 2019 Jun; 44():691-707. PubMed ID: 31221587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms.
    Wallen ZD; Demirkan A; Twa G; Cohen G; Dean MN; Standaert DG; Sampson TR; Payami H
    Nat Commun; 2022 Nov; 13(1):6958. PubMed ID: 36376318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
    Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
    Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota are related to Parkinson's disease and clinical phenotype.
    Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
    Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.